Leukemia in cardio-facio-cutaneous (CFC) syndrome:: A patient with a germline mutation in BRAF proto-oncogene

被引:39
作者
Makita, Yoshio
Narumi, Yoko
Yoshida, Makoto
Niihori, Tetsuya
Kure, Shigeo
Fujieda, Kenji
Matsubara, Yoichi
Aoki, Yoko
机构
[1] Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 9808574, Japan
[2] Asahikawa Med Coll, Dept Pediat, Asahikawa, Hokkaido 078, Japan
[3] Tohoku Univ, Century COE Program 21, Comprehens Res & Educ Ctr Planning Drug Dev & Cli, Sendai, Miyagi 9808574, Japan
关键词
cardio-facio-cutaneous syndrome; KRAS; BRAF; RAS/MAPK; leukemia; JUVENILE MYELOMONOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; NOONAN-SYNDROME; COSTELLO-SYNDROME; MYELOPROLIFERATIVE DISORDER; BLADDER-CARCINOMA; RHABDOMYOSARCOMA; PTPN11; NEUROBLASTOMA; DISEASE;
D O I
10.1097/MPH.0b013e3180547136
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cardio-facio-cutancous (CFC) syndrome is a multiple congenital anomaly/mental retardation syndrome characterized by a distinctive facial appearance, ectodermal abnormalities, and heart defects. Clinically, it overlaps with both Noonan syndrome and Costello syndrome, which are caused by mutations in 2 genes that encode molecules of the RAS/MAPK (mitogen activated protein kinase) pathway (PTPN11 and HRAS, respectively). Recently, mutations in KRAS, BRAF, and MEK1/2 have been identified in patients with CFC syndrome. Somatic mutations in KRAS and BRAF have been identified in various tumors. In contrast, the association with malignancy has not been noticed in CFC syndrome. Here we report a 9-year-old boy diagnosed with CFC syndrome and acute lymphoblastic leukemia. Sequencing analysis of the entire coding region of KRAS and BRAF showed a de novo germline BRAF E501G (1502A -> G) mutation. Molecular diagnosis and careful observations should be considered in children with CFC syndrome because they have germline mutations in proto-oncogenes and might develop malignancy.
引用
收藏
页码:287 / 290
页数:4
相关论文
共 37 条
[1]   Germline mutations in HRAS proto-oncogene cause Costello syndrome [J].
Aoki, Y ;
Niihori, T ;
Kawame, H ;
Kurosawa, K ;
Filocamo, M ;
Kato, K ;
Suzuki, Y ;
Kure, S ;
Matsubara, Y .
NATURE GENETICS, 2005, 37 (10) :1038-1040
[2]   NOONANS-SYNDROME AND ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
ATTARDMONTALTO, SP ;
KINGSTON, JE ;
EDEN, T .
MEDICAL AND PEDIATRIC ONCOLOGY, 1994, 23 (04) :391-392
[3]   Occurrence of myeloproliferative disorder in patients with Noonan syndrome [J].
BaderMeunier, B ;
Tchernia, G ;
Mielot, F ;
Fontaine, JL ;
Thomas, C ;
Lyonnet, S ;
Lavergne, JM ;
Dommergues, JP .
JOURNAL OF PEDIATRICS, 1997, 130 (06) :885-889
[4]   Rhabdomyosarcoma in a patient with cardio-facio-cutaneous syndrome [J].
Bisogno, G ;
Murgia, A ;
Mammi, I ;
Strafella, MS ;
Carli, M .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (05) :424-427
[5]   Juvenile myelomonocytic leukemia and Noonan syndrome [J].
Choong, K ;
Freedman, MH ;
Chitayat, D ;
Kelly, EN ;
Taylor, G ;
Zipursky, A .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (06) :523-527
[6]   NOONAN SYNDROME AND NEUROBLASTOMA [J].
COTTON, JL ;
WILLIAMS, RG .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1995, 149 (11) :1280-1281
[7]  
Feingold M, 1999, J MED GENET, V36, P582
[8]  
Franceschini P, 1999, AM J MED GENET, V86, P174, DOI 10.1002/(SICI)1096-8628(19990910)86:2<174::AID-AJMG17>3.3.CO
[9]  
2-P
[10]   Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome [J].
Fukuda, M ;
Horibe, K ;
Miyajima, Y ;
Matsumoto, K ;
Nagashima, M .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (02) :177-179